Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation-Reference-Cited by-同舟云学术

Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation

Published:1999-09 Issue:3 Volume:48 Page:388-394
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Aitchison Katherine J.,Munro Janet,Wright Padraig,Smith Shulabade,Makoff Andrew J.,Sachse Christoph,Sham Pak C.,Murray Robin M.,Collier David A.,Kerwin Robert W.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.1999.00006.x/fullpdf

Reference41 articles.

1. Genetically variable metabolism of antidepressants and neuroleptic drugs in man.;Dahl;Pharmacogenetics,1993

2. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population.;Agúndez;Clin Pharmacol Ther,1995

3. Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6-an evaluation with the nonparametric maximum likelihood method.;Jerling;Br J Clin Pharmacol,1994

4. Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine: letter.;Bertilsson;Lancet,1993

5. Inherited amplification of an active gene in the cytocrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.;Johansson;Proc Natl Acad Sci USA,1993

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodology for clinical genotyping of CYP2D6 and CYP2C19;Translational Psychiatry;2021-11-22

2. How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?;Frontiers in Genetics;2020-12-08

3. Pharmacogenomics and Psychopharmacology;Seminars in Clinical Psychopharmacology;2020-06-18

4. Cross-validation of technologies for genotypingCYP2D6andCYP2C19;2019-12-26

5. Pharmacogenomics in Psychiatric Disorders;Pharmacogenomics;2019